LEUVEN, Belgium, May 17th, 2017 — ViroVet NV, a leading Belgian biopharmaceutical company active in the development of innovative vaccines and antiviral drugs for livestock, is proud to announce a […]
(15th February 2015) GALVmed recently held a workshop Nairobi (19-20 January 2017) to discuss ongoing research to improve the East Coast Fever (ECF) vaccine. The vaccine, commonly known as Infection […]
As part of GALVmed’s regulatory harmonisation efforts, a new document was developed to provide a summarised overview of the country requirements and procedures needed to register veterinary products in 30 […]
(9th September 2016) The University of Dundee and the Global Alliance for Livestock Veterinary Medicines (GALVmed) have partnered to develop a simple and effective device that tests for a cattle disease […]
Vaccine will protect against the fourth highest foodborne hazard ranked by WHO, which causes approximately 30% of epilepsy cases in humans in the developing world. (20/07/2016) – An innovative vaccine […]
GALVmed and AgResults are delighted to announce the launch of the Brucellosis Vaccine Initiative, a US $30 million prize competition aimed at incentivising animal health companies to develop a vaccine […]
We were invited by one of our key funders, the UK Department for International Development to participate within the British Government marquee at the Royal Highland Show in Edinburgh. The […]
World Animal Vaccination Day promotes the importance of vaccination in all animals. More than 100 animal diseases can be prevented through vaccination, helping to protect many species including dogs, cats, […]
A recent Guardian article has showcased the research, technical innovation and knowledge-sharing partnership between the UK Government and the Bill & Melinda Gates Foundation that is aimed at transforming the […]
